Community-associated methicillin-resistant Staphylococcus aureus, Switzerland

Emerg Infect Dis. 2005 Jun;11(6):962-5. doi: 10.3201/eid1106.041308.

Abstract

Two case-control studies evaluated the prevalence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) carriage at hospital admission and characteristics of patients with CA-MRSA. Among 14,253 patients, CA-MRSA prevalence was 0.9/1,000 admissions. Although 5 CA-MRSA isolates contained Panton-Valentine leukocidin, only 1 patient had a previous skin infection. No easily modifiable risk factor for CA-MRSA was identified.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carrier State / epidemiology*
  • Carrier State / microbiology
  • Case-Control Studies
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / microbiology
  • Female
  • Humans
  • Male
  • Methicillin Resistance*
  • Middle Aged
  • Patient Admission / statistics & numerical data
  • Prevalence
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Switzerland / epidemiology